In their 2018 cholesterol guidelines, the American Heart Association and American College of Cardiology recommend individualized risk and treatment options.
Second study shows no significant results for vitamin D supplementation vs placebo.
Whites with heart failure more likely to be hospitalized for higher-clinical-acuity visits.
Each one-standard deviation increase in air temperature tied to 2.8% reduction in MI risk
The effect of Invokana on CV risk was evaluated in the CANVAS (CANagliflozin cardioVascular Assessment Study) Program in >10,000 adults with T2D who had established CV disease or were at risk for CV disease with ≥2 risk factors.
Statin use vs non-use among patients hospitalized with dialysis-requiring acute kidney injury is associated with decreased risks of 1-year and in-hospital all-cause mortality, a study found.
In a study, progression of calcification did not increase until eGFR falls below 40 mL/min/1.73 m2.
Patients who received hemodialysis 6 times per week instead of 3 showed improvements in biomarkers of mineral metabolism and left ventricular remodeling.
Higher magnesium levels are associated with a lower risk of peripheral artery disease, but only among individuals without impaired renal function.
In the first year after starting dialysis, women have 16% increased odds of major adverse cardiovascular events compared with men.
In asymptomatic patients, AUC was higher for AAC than for Framingham Risk Score at all time points.
Even greater risk for mortality, CV events in presence of several high-variability metabolic parameters
Findings based on data reweighted to reflect the adult population with diabetes in the US.
Despite having been withdrawn, albiglutide is superior to placebo for reducing cardiovascular events
Myocardial infarction following the kidney stone procedure is twice as likely among patients with 3 to 4 components of metabolic syndrome vs no components.
Patients with, without chronic kidney disease have less acute renal failure with PCI.
Kidneys of neonates with left heart obstruction consistently found to be larger than normal
Low eGFR and worsening renal function are independently associated with a nearly 3-fold increased mortality risk among patients undergoing percutaneous coronary intervention.
Salt intake below 6 g/day is associated with increased odds of all-cause and cardiovascular in patients on hemodialysis, Japanese study shows.
Among US dialysis patients, cardiovascular event rates are highest in those with diabetic nephropathy and lowest among those with IgA nephropathy.
New study suggests sodium intake is associated with cardiovascular disease and stroke only when mean sodium intake exceeds 5 grams per day.
In a study, percutaneous coronary intervention was associated with a 72% decreased risk of acute renal failure compared with coronary artery bypass grafting in patients with chronic kidney disease.
Surgical procedure can correct calcium and phosphorus abnormalities and improve coronary artery calcification, study finds.
A study of Medicare patients found that atrial fibrillation was nearly twice as likely to develop in those with vs without gout.
DOAC users with eGFRs less than 60 mL/min/1.73m2 had a 23% higher risk for bleeding than warfarin users.
Insufficient evidence for adding to traditional CVD risk assessment in asymptomatic adults.
Association seen between marital status and risk, prognosis of coronary heart disease or stroke
Apixaban recipients had a 28% lower risk for major bleeding compared with patients treated with warfarin.
Composite outcome occurred in 12.9%; 50.1% of events in second to fifth years.
Lower incidence of major cardiovascular events with Mediterranean diet supplemented with oil, nuts.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)